Skip to main content
SpringerLink
Log in

Antineoplastics/methylprednisolone/netupitant/palonosetron

Various toxicities: 4 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. "Demographic details of all patients (22-year-old man, 41-year old woman, 61-year-old woman and 33-year-old woman) were obtained through personal communication with the author."

Reference

  • Zilioli VR, et al. Safety and efficacy of netupitant/palonosetron and dexamethasone in classical Hodgkin's lymphoma patients with inadequate chemotherapy-induced nausea and vomiting prophylaxis with palonosetron and dexamethasone: A single-center real-life experience. International Journal of Hematologic Oncology 9: 286, No. 1, Mar 2020. Available from: URL: http://doi.org/10.2217/ijh-2020-0001

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Antineoplastics/methylprednisolone/netupitant/palonosetron. Reactions Weekly 1809, 45 (2020). https://doi.org/10.1007/s40278-020-79829-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-79829-6

Search

Navigation